西洛他唑联合尼可地尔对LEAOD患者baPWV、ABI指数及CD36水平的影响-东南大学学报医学版

西洛他唑联合尼可地尔对LEAOD患者baPWV、ABI指数及CD36水平的影响

单位：1. 连云港市第一人民医院血管外科, 江苏连云港 222000;
2. 南京鼓楼医院血管外科, 江苏南京 210000

分类号：R543.5

出版年·卷·期（页码）：2018·37·第六期（1014-1018）

摘要：

目的：探讨西洛他唑联合尼可地尔对下肢动脉硬化闭塞症（LEAOD）患者臂踝脉搏波传导速度（baPWV）、踝肱指数（ABI）及清道夫受体CD36水平的影响。方法：选取116例LEAOD患者作为研究对象，采用随机数字表法分为对照组和治疗组，每组58例。对照组患者采用西洛他唑治疗，治疗组在西洛他唑治疗的基础上联合尼可地尔治疗，比较两组临床治疗效果，治疗前后baPWV、ABI和CD36水平以及不良反应发生情况。结果：治疗结束后，有效率对照组仅为74.1%，而治疗组为91.4%，两组差异有统计学意义（P<0.05）。治疗前两组baPWV、ABI以及CD36水平均无显著性差异，治疗后两组均baPWV、CD36水平显著降低，ABI显著升高，但与对照组相比，治疗组baPWV和CD36水平降低更为明显，ABI升高更为显著（均P<0.05）。对照组和治疗组不良反应发生率分别为15.5%、13.8%，差异无统计学意义（P>0.05）。结论：西洛他唑联合尼可地尔对LEAOD患者治疗效果显著，有效降低了baPWV值和CD36水平，提高了ABI，而且安全性较高，值得在临床广泛应用。

Objective:To investigate the effect of cilostazol combined with nicorandil on brachial-ankle pulse wave velocity (baPWV), ankle-brachial index (ABI) and scavenger receptor CD36 in patients with lower extremity arteriosclerotic occlusive disease (LEAOD). Methods:A total of 116 patients with LEAOD were entrolled in this study. According to the random number table, the patients were divided into control group and treatment group, 58 cases in each group. The control group were treated with cilostazol and the treatment group were given cilostazol combined with nicorandil. The clinical effects, baPWV, ABI and the levels of CD36 before and after treatment were compared between the two groups. At the same time, the incidence of adverse reactions was compared between the two groups. Results:After the treatment, the effective rate was only 74.1% in the control group, but 91.4% in treatment group, the difference was statistically significant (P<0.05);There was no significant difference in baPWV, ABI and CD36 levels between the two groups before treatment. After treatment, baPWV and the levels of CD36 in both groups were significantly decreased, ABI was significantly increased, and baPWV and the levels of CD36 decreased more and ABI increased more in the treatment group (all P<0.05). The incidence of adverse reactions was 15.5% in the control group and 13.8% in treatment group respectively, there was no significant difference between the two groups (P>0.05). Conclusion:Cilostazol combined with nicorandil has a significant therapeutic effect on patients with LEAOD, it can effectively reduce the baPWV and CD36 level, increase the ABI and high safety, which is worth widely used in clinical practice.

参考文献：

[1] GRAY C,GOODMAN P,CULLEN P,et al.Screening for peripheral arterial disease and carotid artery disease in patients with abdominal aortic aneurysm[J].Angiology,2016,67(4):346-349.
[2] JAHN J,ZIMMERMANN W,MOYSIDIS T,et al.Ankle brachial index and pneumoplethysmographic pulse-volume recordings for detection of peripheral arterial disease[J].Vasa,2014,43(3):202-208.
[3] CHEN Y,KENNEDY D J,RAMAKRISHNAN D P,et al.Oxidized LDL-bound CD36 recruits a Na⁺/K⁺-ATPase-Lyn complex in macrophages that promotes atherosclerosis[J].Sci Signal,2015,8(393):ra91.
[4] WONG H S,JAUMOUILLÉ V,FREEMAN S A,et al.Chemokine signaling enhances CD36 responsiveness toward oxidized low-density lipoproteins and accelerates foam cell formation[J].Cell Rep,2016,14(12):2859-2871.
[5] 田强强,吴斌.动脉硬化的中西医治疗研究进展[J].中西医结合心脑血管病杂志,2016,14(24):2903-2905.
[6] 周红君,袁伟.尼可地尔对老年急性ST段抬高型心肌梗死患者BNP水平与冠脉血流影响的研究[J].东南大学学报(医学版),2016,35(3):405-409.
[7] 中华医学会外科学分会血管外科学组.下肢动脉硬化性闭塞症治疗指南[J].中国实用外科杂志,2008,28(11):923-924.
[8] 卫生部心血管系统药物临床药理基地.心血管系统药物临床研究指导原则[J].中国临床药理学杂志,1988,4(4):245-254.
[9] 周志向,陈圆,周家春,等.西洛他唑联合前列地尔治疗下肢动脉硬化闭塞症的临床观察[J].中国药房,2017,28(17):2402-2405.
[10] 舒畅,何昊.下肢动脉硬化闭塞症术前评估主要方法及评价[J].中国实用外科杂志,2016,36(12):1334-1337.
[11] 黄斌,陈熹阳,赵纪春,等.外科结合腔内治疗下肢动脉硬化闭塞症[J].中国普外基础与临床杂志,2015,22(8):926-928.
[12] 王云鹏,姚野,孙庆峰,等.老年下肢动脉硬化闭塞症相关危险因素分析及介入手术应用[J].中华老年多器官疾病杂志,2017,16(10):766-769.
[13] 李建鹏,王峥.血栓通联合前列地尔治疗下肢动脉硬化闭塞症的有效性及对其血液流变学的影响[J].中国实验方剂学杂志,2016,22(6):159-162.
[14] 涂强,曹政.西洛他唑的药理作用机制及其临床应用的研究进展[J].中国动脉硬化杂志,2017,25(6):644-648.
[15] 范永臻,黄河,吴名星,等.尼可地尔对稳定型心绞痛患者PCI术后冠状动脉微循环阻力指数的影响[J].国际心血管病杂志,2015,42(6):412-415.
[16] SAJI N,KIMURA K,YAGITA Y,et al.Comparison of arteriosclerotic indicators in patients with ischemic stroke:ankle-brachial index,brachial-ankle pulse wave velocity and cardio-ankle vascular index[J].Hypertens Res,2015,38(5):323-328.
[17] LI T,WU X,CHEN X,et al.Ankle-brachial index and brachial-ankle pulse wave velocity are risk factors for ischemic stroke in patients with type 2 diabetes[J].Neural Regen Res,2017,12(11):1853-1859.
[18] QIN M,WANG L,LI F,et al.Oxidized LDL activated eosinophil polarize macrophage phenotype from M2 to M1 through activation of CD36 scavenger receptor[J].Atherosclerosis,2017,263(8):82-91.
[19] 陈文娜,郭胜男,王俊岩,等.下肢动脉硬化闭塞症患者股动脉粥样硬化斑块中巨噬细胞极化表型与自噬信号相关性的研究[J].药学学报,2016,51(1):68-74.
[20] 张玉刚.西洛他唑治疗糖尿病下肢血管病变的临床疗效观察[J].临床医药文献杂志,2016,3(55):11028-11029.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录